VAREX IMAGING (VREX)
(Real Time Quote from BATS)
$17.04 USD
+0.12 (0.71%)
Updated Apr 19, 2024 12:04 PM ET
5-Strong Sell of 5 5
B Value D Growth B Momentum B VGM
Income Statements
Fiscal Year end for VAREX IMAGING falls in the month of September.
All items in Millions except EPS data.
9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 | |
---|---|---|---|---|---|
Sales | 893 | 859 | 818 | 738 | 781 |
Cost Of Goods | 603 | 576 | 547 | 548 | 524 |
Gross Profit | 290 | 284 | 272 | 190 | 257 |
Selling & Adminstrative & Depr. & Amort Expenses | 213 | 195 | 197 | 224 | 211 |
Income After Depreciation & Amortization | 77 | 88 | 74 | -34 | 46 |
Non-Operating Income | -17 | -4 | -3 | -8 | -3 |
Interest Expense | 29 | 40 | 42 | 31 | 21 |
Pretax Income | 31 | 45 | 29 | -73 | 22 |
Income Taxes | -17 | 14 | 11 | -15 | 6 |
Minority Interest | 1 | 1 | 1 | 1 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 49 | 31 | 18 | -57 | 16 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 48 | 30 | 17 | -58 | 16 |
Depreciation Footnote | 9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 113 | 133 | 121 | 14 | 92 |
Depreciation & Amortization (Cash Flow) | 36 | 45 | 47 | 47 | 46 |
Income After Depreciation & Amortization | 77 | 88 | 74 | -34 | 46 |
Earnings Per Share Data | 9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 |
---|---|---|---|---|---|
Average Shares | 50.30 | 41.60 | 40.30 | 38.80 | 38.60 |
Diluted EPS Before Non-Recurring Items | 1.27 | 0.73 | 1.31 | 0.08 | 1.30 |
Diluted Net EPS (GAAP) | 1.08 | 0.73 | 0.43 | -1.49 | 0.40 |
Fiscal Year end for VAREX IMAGING falls in the month of September.
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 190.00 | 227.40 | 232.20 | 228.20 |
Cost Of Goods | NA | 132.90 | 149.40 | 155.90 | 155.50 |
Gross Profit | NA | 57.10 | 78.00 | 76.30 | 72.70 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 52.90 | 53.70 | 52.10 | 57.10 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 4.20 | 24.30 | 24.20 | 15.60 |
Non-Operating Income | NA | 2.50 | -16.10 | 0.20 | -0.50 |
Interest Expense | NA | 7.30 | 7.20 | 7.30 | 7.30 |
Pretax Income | NA | -0.60 | 1.00 | 17.10 | 7.80 |
Income Taxes | NA | -0.20 | -31.00 | 7.90 | 3.50 |
Minority Interest | NA | 0.10 | 0.10 | 0.10 | 0.20 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -0.40 | 32.00 | 9.20 | 4.30 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -0.50 | 31.90 | 9.10 | 4.10 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 40.60 | 50.50 | 50.40 | 40.50 |
Diluted EPS Before Non-Recurring Items | NA | 0.06 | 0.45 | 0.37 | 0.26 |
Diluted Net EPS (GAAP) | NA | -0.01 | 0.69 | 0.21 | 0.10 |